Evidence for ZNF469 includes strong human genetic support from syndromic disease (brittle cornea syndrome) and replicated GWAS signals, although enrichment of rare pathogenic variants in sporadic keratoconus remains inconsistent across cohorts. This evidence concerns the gene ZNF469 and keratoconus.